AACR: Trio of studies highlights promising early results with new cancer therapies and targets
University of Texas MD Anderson Cancer CenterThree early-phase clinical studies presented by researchers from The University of Texas MD Anderson Cancer Center at the American Association for Cancer Research (AACR) Annual Meeting 2024 show promising initial data for patients with lymphoma, gastric or gastroesophageal junction cancers, and specific molecularly selected tumors.